Skip to content
2000
image of Unveiling the Influence of Culture Conditions on Mesenchymal Stem Cells: A Transcriptome Sequencing Study

Abstract

Aims

To optimize the culture process of Mesenchymal Stem Cells (MSCs) and enhance their biological functions.

Background

MSCs have shown great potential in treating various diseases due to their low immunogenicity and potent paracrine effects. However, the inherent heterogeneity of MSC populations, which can vary depending on the culture conditions, may challenge large-scale clinical application.

Objective

This study investigates the inconsistency of MSCs cultured in different media, from the transcriptional level to biological functions.

Method

RNA sequencing was used to identify different expressed genes of MSCs separated and expanded in three media, which were then validated with qPCR. assays, including proliferation, tube formation, wound healing, multilineage differentiation, paracrine secretome and injured hepatocyte protection assay, were performed to verify the potential differences among three groups.

Result

MSCs cultured in platelet lysate-containing medium exhibited high expression of genes involved in extracellular matrix regulation, collagen metabolic processes, and angiogenesis, whereas those cultured in serum-free medium demonstrated high expression of genes associated with DNA replication and chromosome segregation. MSCs cultured under serum-containing medium indicated high levels of genes associated with extracellular matrix regulation, cartilage development, and chemotaxis. The results of functional comparative experiments were consistent with the differences in their gene expression patterns. Notably, MSCs cultured in the serum-containing system exhibited greater protective effect against hepatocyte activity.

Conclusion

Different culture conditions affect the biological functions of MSCs. Optimal conditions should be investigated for applications. Next, an model should be established to evaluate differences in MSC tissue repair function under various culture conditions.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cpb/10.2174/0113892010375906250619115932
2025-07-10
2025-09-14

  • From This Site

    /content/journals/cpb/10.2174/0113892010375906250619115932
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Friedenstein A.J. Chailakhjan R.K. Lalykina K.S. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Prolif. 1970 3 4 393 403 10.1111/j.1365‑2184.1970.tb00347.x 5523063
    [Google Scholar]
  2. Friedenstein A.J. Deriglasova U.F. Kulagina N.N. Panasuk A.F. Rudakowa S.F. Luriá E.A. Ruadkow I.A. Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. Exp. Hematol. 1974 2 2 83 92 4455512
    [Google Scholar]
  3. Bartolucci J. Verdugo F.J. González P.L. Larrea R.E. Abarzua E. Goset C. Rojo P. Palma I. Lamich R. Pedreros P.A. Valdivia G. Lopez V.M. Nazzal C. Alcayaga-Miranda F. Cuenca J. Brobeck M.J. Patel A.N. Figueroa F.E. Khoury M. Safety and efficacy of the intravenous infusion of umbilical cord mesenchymal stem cells in patients with heart failure: A phase 1/2 randomized controlled trial (RIMECARD Trial [Randomized clinical trial of intravenous infusion umbilical cord mesenchymal stem cells on cardiopathy]). Circ. Res. 2017 121 10 1192 1204 10.1161/CIRCRESAHA.117.310712 28974553
    [Google Scholar]
  4. Yun C.W. Lee S.H. Enhancement of functionality and therapeutic efficacy of cell-based therapy using mesenchymal stem cells for cardiovascular disease. Int. J. Mol. Sci. 2019 20 4 982 10.3390/ijms20040982 30813471
    [Google Scholar]
  5. Matta A. Nader V. Lebrin M. Gross F. Prats A.C. Cussac D. Galinier M. Roncalli J. Pre-conditioning methods and novel approaches with mesenchymal stem cells therapy in cardiovascular disease. Cells 2022 11 10 1620 10.3390/cells11101620 35626657
    [Google Scholar]
  6. Venkataramana N.K. Kumar S.K.V. Balaraju S. Radhakrishnan R.C. Bansal A. Dixit A. Rao D.K. Das M. Jan M. Gupta P.K. Totey S.M. Open-labeled study of unilateral autologous bone-marrow-derived mesenchymal stem cell transplantation in Parkinson’s disease. Transl. Res. 2010 155 2 62 70 10.1016/j.trsl.2009.07.006 20129486
    [Google Scholar]
  7. Petrou P. Gothelf Y. Argov Z. Gotkine M. Levy Y.S. Kassis I. Vaknin-Dembinsky A. Ben-Hur T. Offen D. Abramsky O. Melamed E. Karussis D. Safety and clinical effects of mesenchymal stem cells secreting neurotrophic factor transplantation in patients with amyotrophic lateral sclerosis. JAMA Neurol. 2016 73 3 337 344 10.1001/jamaneurol.2015.4321 26751635
    [Google Scholar]
  8. Soufi K.H. Castillo J.A. Rogdriguez F.Y. DeMesa C.J. Ebinu J.O. Potential role for stem cell regenerative therapy as a treatment for degenerative disc disease and low back pain: A systematic review. Int. J. Mol. Sci. 2023 24 10 8893 10.3390/ijms24108893 37240236
    [Google Scholar]
  9. Mohamadnejad M. Alimoghaddam K. Mohyeddin-Bonab M. Bagheri M. Bashtar M. Ghanaati H. Baharvand H. Ghavamzadeh A. Malekzadeh R. Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis. Arch. Iran Med. 2007 10 4 459 466 17903050
    [Google Scholar]
  10. Hu C. Wu Z. Li L. Mesenchymal stromal cells promote liver regeneration through regulation of immune cells. Int. J. Biol. Sci. 2020 16 5 893 903 10.7150/ijbs.39725 32071558
    [Google Scholar]
  11. Shi M. Li Y.Y. Xu R.N. Meng F.P. Yu S.J. Fu J.L. Hu J.H. Li J.X. Wang L.F. Jin L. Wang F.S. Mesenchymal stem cell therapy in decompensated liver cirrhosis: A long-term follow-up analysis of the randomized controlled clinical trial. Hepatol. Int. 2021 15 6 1431 1441 10.1007/s12072‑021‑10199‑2 34843069
    [Google Scholar]
  12. Wang M. Liang C. Hu H. Zhou L. Xu B. Wang X. Han Y. Nie Y. Jia S. Liang J. Wu K. Intraperitoneal injection (IP), Intravenous injection (IV) or anal injection (AI)? Best way for mesenchymal stem cells transplantation for colitis. Sci. Rep. 2016 6 1 30696 10.1038/srep30696 27488951
    [Google Scholar]
  13. Li A. Guo F. Pan Q. Chen S. Chen J. Liu H. Pan Q. Mesenchymal stem cell therapy: Hope for patients with systemic lupus erythematosus. Front. Immunol. 2021 12 728190 10.3389/fimmu.2021.728190 34659214
    [Google Scholar]
  14. Oh J.Y. Lee R.H. Mesenchymal stromal cells for the treatment of ocular autoimmune diseases. Prog. Retin. Eye Res. 2021 85 100967 10.1016/j.preteyeres.2021.100967 33775824
    [Google Scholar]
  15. Saeedi M. Nezhad M.S. Mehranfar F. Golpour M. Esakandari M.A. Rashmeie Z. Ghorbani M. Nasimi F. Hoseinian S.N. Biological aspects and clinical applications of mesenchymal stem cells: Key features you need to be aware of. Curr. Pharm. Biotechnol. 2021 22 2 200 215 10.2174/1389201021666200907121530 32895040
    [Google Scholar]
  16. Mastrolia I. Foppiani E.M. Murgia A. Candini O. Samarelli A.V. Grisendi G. Veronesi E. Horwitz E.M. Dominici M. Challenges in clinical development of mesenchymal stromal/stem cells: Concise review. Stem Cells Transl. Med. 2019 8 11 1135 1148 10.1002/sctm.19‑0044 31313507
    [Google Scholar]
  17. Levy O. Kuai R. Siren E.M.J. Bhere D. Milton Y. Nissar N. De Biasio M. Heinelt M. Reeve B. Abdi R. Alturki M. Fallatah M. Almalik A. Alhasan A.H. Shah K. Karp J.M. Shattering barriers toward clinically meaningful MSC therapies. Sci. Adv. 2020 6 30 eaba6884 10.1126/sciadv.aba6884 32832666
    [Google Scholar]
  18. Rady D. Abbass M.M.S. El-Rashidy A.A. El Moshy S. Radwan I.A. Dörfer C.E. Fawzy El-Sayed K.M. Mesenchymal stem/progenitor cells: The prospect of human clinical translation. Stem Cells Int. 2020 2020 1 45 10.1155/2020/8837654 33953753
    [Google Scholar]
  19. Dunn C.M. Kameishi S. Grainger D.W. Okano T. Strategies to address mesenchymal stem/stromal cell heterogeneity in immunomodulatory profiles to improve cell-based therapies. Acta Biomater. 2021 133 114 125 10.1016/j.actbio.2021.03.069 33857693
    [Google Scholar]
  20. Sun C. Wang L. Wang H. Huang T. Yao W. Li J. Zhang X. Single-cell RNA-seq highlights heterogeneity in human primary Wharton’s jelly mesenchymal stem/stromal cells cultured in vitro. Stem Cell Res. Ther. 2020 11 1 149 10.1186/s13287‑020‑01660‑4 32252818
    [Google Scholar]
  21. Wang Z. Chai C. Wang R. Feng Y. Huang L. Zhang Y. Xiao X. Yang S. Zhang Y. Zhang X. Single-cell transcriptome atlas of human mesenchymal stem cells exploring cellular heterogeneity. Clin. Transl. Med. 2021 11 12 e650 10.1002/ctm2.650 34965030
    [Google Scholar]
  22. Rennerfeldt D.A. Van Vliet K.J. Concise review: When colonies are not clones: Evidence and implications of intracolony heterogeneity in mesenchymal stem cells. Stem Cells 2016 34 5 1135 1141 10.1002/stem.2296 26840390
    [Google Scholar]
  23. Rennerfeldt D.A. Raminhos J.S. Leff S.M. Manning P. Van Vliet K.J. Emergent heterogeneity in putative mesenchymal stem cell colonies: Single-cell time lapsed analysis. PLoS One 2019 14 4 e0213452 10.1371/journal.pone.0213452 30943212
    [Google Scholar]
  24. Selich A. Daudert J. Hass R. Philipp F. von Kaisenberg C. Paul G. Cornils K. Fehse B. Rittinghausen S. Schambach A. Rothe M. Massive clonal selection and transiently contributing clones during expansion of mesenchymal stem cell cultures revealed by Lentiviral RGB-barcode technology. Stem Cells Transl. Med. 2016 5 5 591 601 10.5966/sctm.2015‑0176 27034413
    [Google Scholar]
  25. Wang S. Wang Z. Su H. Chen F. Ma M. Yu W. Ye G. Cen S. Mi R. Wu X. Deng W. Feng P. Zeng C. Shen H. Wu Y. Effects of long-term culture on the biological characteristics and RNA profiles of human bone-marrow-derived mesenchymal stem cells. Mol. Ther. Nucleic Acids 2021 26 557 574 10.1016/j.omtn.2021.08.013 34631285
    [Google Scholar]
  26. Kim G. Eom Y.W. Baik S.K. Shin Y. Lim Y.L. Kim M.Y. Kwon S.O. Chang S.J. Therapeutic effects of mesenchymal stem cells for patients with chronic liver diseases: Systematic review and meta-analysis. J. Korean Med. Sci. 2015 30 10 1405 1415 10.3346/jkms.2015.30.10.1405 26425036
    [Google Scholar]
  27. Bui H.T.H. Nguyen L.T. Than U.T.T. Influences of xeno-free media on mesenchymal stem cell expansion for clinical application. Tissue Eng. Regen. Med. 2021 18 1 15 23 10.1007/s13770‑020‑00306‑z 33150562
    [Google Scholar]
  28. Jakl V. Popp T. Haupt J. Port M. Roesler R. Wiese S. Friemert B. Rojewski M.T. Schrezenmeier H. Effect of expansion media on functional characteristics of bone marrow-derived mesenchymal stromal cells. Cells 2023 12 16 2105 10.3390/cells12162105 37626914
    [Google Scholar]
  29. Zou M.S. Song Q.J. Yin T.Y. Xu H.T. Nie G.M. Vitamin D. Vitamin D activates miR-126a-5p to target GSK-3β and alleviates systemic lupus erythematosus in MRL/LPR mice. Curr. Pharm. Biotechnol. 2023 24 14 1803 1811 10.2174/1389201024666230330075550 36999179
    [Google Scholar]
  30. Li Z. Hezam K. Mo R. Wang C. Liu Y. Anti-inflammatory effects of mesenchymal stem cells and their secretomes in pneumonia. Curr. Pharm. Biotechnol. 2022 23 9 1153 1167 10.2174/1389201022666210907115126 34493193
    [Google Scholar]
  31. Cory S. Huang D.C.S. Adams J.M. The Bcl-2 family: Roles in cell survival and oncogenesis. Oncogene 2003 22 53 8590 8607 10.1038/sj.onc.1207102 14634621
    [Google Scholar]
  32. Zhao Y. Ye W. Wang Y.D. Chen W.D. HGF/c-Met: A key promoter in liver regeneration. Front. Pharmacol. 2022 13 808855 10.3389/fphar.2022.808855 35370682
    [Google Scholar]
  33. Boldyreva M.A. Shevchenko E.K. Molokotina Y.D. Makarevich P.I. Beloglazova I.B. Zubkova E.S. Dergilev K.V. Tsokolaeva Z.I. Penkov D. Hsu M.N. Hu Y.C. Parfyonova Y.V. Transplantation of adipose stromal cell sheet producing hepatocyte growth factor induces pleiotropic effect in ischemic skeletal muscle. Int. J. Mol. Sci. 2019 20 12 3088 10.3390/ijms20123088 31238604
    [Google Scholar]
  34. Meng H. Wei F. Zhou Y. Hu L. Ge Z. Jin J. Wang H. Wu C. Overexpression of hepatocyte growth factor in dental pulp stem cells ameliorates the severity of psoriasis by reducing inflammatory responses. Stem Cells Dev. 2021 30 17 876 889 10.1089/scd.2021.0129 34155928
    [Google Scholar]
  35. Liu C. Xu Y. Lu Y. Du P. Li X. Wang C. Guo P. Diao L. Lu G. Mesenchymal stromal cells pretreated with proinflammatory cytokines enhance skin wound healing via IL-6-dependent M2 polarization. Stem Cell Res. Ther. 2022 13 1 414 10.1186/s13287‑022‑02934‑9 35964139
    [Google Scholar]
  36. Yew T.L. Hung Y.T. Li H.Y. Chen H.W. Chen L.L. Tsai K.S. Chiou S.H. Chao K.C. Huang T.F. Chen H.L. Hung S.C. Enhancement of wound healing by human multipotent stromal cell conditioned medium: The paracrine factors and p38 MAPK activation. Cell Transplant. 2011 20 5 693 706 10.3727/096368910X550198 21176394
    [Google Scholar]
  37. Wan M. Li C. Zhen G. Jiao K. He W. Jia X. Wang W. Shi C. Xing Q. Chen Y.F. Jan De Beur S. Yu B. Cao X. Injury-activated transforming growth factor β controls mobilization of mesenchymal stem cells for tissue remodeling. Stem Cells 2012 30 11 2498 2511 10.1002/stem.1208 22911900
    [Google Scholar]
  38. Engelmann C. Berg T. G-CSF treatment in decompensated liver disease: A double-edged sword? Hepatol. Int. 2022 16 5 979 982 10.1007/s12072‑022‑10379‑8 36053413
    [Google Scholar]
  39. Yu J. Feng Z. Tan L. Pu L. Kong L. Interleukin-11 protects mouse liver from warm ischemia/reperfusion (WI/Rp) injury. Clin. Res. Hepatol. Gastroenterol. 2016 40 5 562 570 10.1016/j.clinre.2015.11.009 27016892
    [Google Scholar]
  40. Zhu M. Lu B. Cao Q. Wu Z. Xu Z. Li W. Yao X. Liu F. IL-11 attenuates liver ischemia/reperfusion injury (IRI) through STAT3 signaling pathway in mice. PLoS One 2015 10 5 e0126296 10.1371/journal.pone.0126296 25946003
    [Google Scholar]
  41. Nishina T. Komazawa-Sakon S. Yanaka S. Piao X. Zheng D.M. Piao J.H. Kojima Y. Yamashina S. Sano E. Putoczki T. Doi T. Ueno T. Ezaki J. Ushio H. Ernst M. Tsumoto K. Okumura K. Nakano H. Interleukin-11 links oxidative stress and compensatory proliferation. Sci. Signal. 2012 5 207 ra5 10.1126/scisignal.2002056 22253262
    [Google Scholar]
  42. Nicoletti V.G. Pajer K. Calcagno D. Pajenda G. Nógrádi A. The role of metals in the neuroregenerative action of BDNF, GDNF, NGF and other neurotrophic factors. Biomolecules 2022 12 8 1015 10.3390/biom12081015 35892326
    [Google Scholar]
/content/journals/cpb/10.2174/0113892010375906250619115932
Loading
Unveiling the Influence of Culture Conditions on Mesenchymal Stem Cells: A Transcriptome Sequencing Study
Bentham Science Publishers ; https://doi.org/10.2174/0113892010375906250619115932
/content/journals/cpb/10.2174/0113892010375906250619115932
/content/journals/cpb/10.2174/0113892010375906250619115932
Loading

Data & Media loading...

Supplements

Supplementary material is available on the publisher’s website along with the published article.

file format download Download

  • Article Type:     Research Article
Keywords: Wharton’s jelly mesenchymal stem cells ; population heterogeneity ; Serum-free ; liver injury ; transcriptome profiles ; culture conditions

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test